AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of GBP 282.20 billion. The enterprise value is 331.83 billion.

Market Cap	282.20B
Enterprise Value	331.83B

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 83.36.

PE Ratio	83.36
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.80, with an EV/FCF ratio of 23.30.

EV / Earnings	98.02
EV / Sales	7.45
EV / EBITDA	15.80
EV / EBIT	23.54
EV / FCF	23.30

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 20.29.

Current Ratio	0.66
Quick Ratio	0.43
Debt / Equity	20.29
Debt / EBITDA	2.57
Debt / FCF	3.83
Interest Coverage	6.35

Financial Efficiency

Return on equity (ROE) is 62.29% and return on invested capital (ROIC) is 15.62%.

Return on Equity (ROE)	62.29%
Return on Assets (ROA)	8.25%
Return on Invested Capital (ROIC)	15.62%
Return on Capital Employed (ROCE)	18.49%
Revenue Per Employee	818,144
Profits Per Employee	61,549
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	4.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.65% in the last 52 weeks. The beta is 0.56, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+11.65%
50-Day Moving Average	181.11
200-Day Moving Average	181.60
Relative Strength Index (RSI)	78.93
Average Volume (20 Days)	30,720

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.22

Income Statement

In the last 12 months, AbbVie had revenue of GBP 45.00 billion and earned 3.39 billion in profits. Earnings per share was 1.91.

Revenue	45.00B
Gross Profit	31.64B
Operating Income	14.24B
Pretax Income	2.97B
Net Income	3.39B
EBITDA	20.93B
EBIT	14.24B
Earnings Per Share (EPS)	1.91

Full Income Statement

Balance Sheet

The company has 4.44 billion in cash and 54.52 billion in debt, giving a net cash position of -50.08 billion.

Cash & Cash Equivalents	4.44B
Total Debt	54.52B
Net Cash	-50.08B
Net Cash Per Share	n/a
Equity (Book Value)	2.69B
Book Value Per Share	1.50
Working Capital	-10.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.02 billion and capital expenditures -778.00 million, giving a free cash flow of 14.24 billion.

Operating Cash Flow	15.02B
Capital Expenditures	-778.00M
Free Cash Flow	14.24B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.31%, with operating and profit margins of 31.64% and 7.59%.

Gross Margin	70.31%
Operating Margin	31.64%
Pretax Margin	6.60%
Profit Margin	7.59%
EBITDA Margin	46.52%
EBIT Margin	31.64%
FCF Margin	31.65%

Dividends & Yields

This stock pays an annual dividend of 4.96, which amounts to a dividend yield of 2.52%.

Dividend Per Share	4.96
Dividend Yield	2.52%
Dividend Growth (YoY)	4.74%
Years of Dividend Growth	10
Payout Ratio	257.71%
Buyback Yield	-0.06%
Shareholder Yield	2.46%
Earnings Yield	1.20%
FCF Yield	5.05%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.08
Piotroski F-Score	n/a